Profusa, Inc. Common Stock(PFSA)Earnings, Financials & Key Ratios
PFSA•NASDAQ
Price updated Jun 19, 2026
AboutA digital-health company developing tissue-integrating biosensors (e.g. the Lumee™ Oxygen Platform) to continuously monitor body chemistry and provide AI-powered health insights, targeting chronic conditions such as diabetes and critical limb ischemiaShow more
- Revenue$0
- EBITDA-$5M+19.9%
- Net Income-$9M+10.2%
- EPS (Diluted)-21.00+9.7%
PFSA Key Insights
Profusa, Inc. Common Stock (PFSA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Weak momentum: RS Rating 1 (bottom 1%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when PFSA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
PFSA Price & Volume
Profusa, Inc. Common Stock (PFSA) stock price & volume — 10-year historical chart
Loading chart...
PFSA Growth Metrics
Profusa, Inc. Common Stock (PFSA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-706.78%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-73.91%
Return on Capital
10 Years-
5 Years-
3 Years-
Last Year-
PFSA Peer Comparison
Profusa, Inc. Common Stock (PFSA) competitors in Medical Devices and Procedure Tools — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 DXCM | 27.96B | 72.47 | 34.67 | 15.6% | 19.31% | 33.83% | 0.51 | |
 ABT | 153.68B | 88.38 | 11.57 | 4.59% | 31.88% | 27.26% | 0.32 | |
 SENS | 281.69M | 6.74 | -4.06 | 56.89% | -214.16% | -130% | 0.68 | |
 PODD | 10.23B | 145.76 | 41.89 | 30.73% | 10.44% | 21.38% | 0.69 | |
 TNDM | 1.05B | 15.30 | -5.03 | 7.93% | -9.2% | -68.29% | 2.86 | |
 LIVN | 4.31B | 78.50 | -17.64 | 10.74% | 7.47% | 9.13% | 0.39 | |
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 | |
 MASI | 9.42B | 179.95 | -64.27 | -27.1% | 4.9% | 9.08% | 0.78 |
Compare PFSA vs Peers
Profusa, Inc. Common Stock (PFSA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PFSA Income Statement
Profusa, Inc. Common Stock (PFSA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
Sales/Revenue | 0 | 0 | 0 | 0 | 0 |
Revenue Growth % | - | - | - | - | - |
Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 |
COGS % of Revenue | - | - | - | - | - |
Gross Profit | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% |
Gross Margin % | - | - | - | - | - |
Gross Profit Growth % | - | - | - | - | - |
Operating Expenses | 11.69M | 11.14M | 6.07M | 4.5M | 24.41M |
OpEx % of Revenue | - | - | - | - | - |
Selling, General & Admin | 4.77M | 5.24M | 4.08M | 2.99M | 22.29M |
SG&A % of Revenue | - | - | - | - | - |
Research & Development | 7.66M | 4.2M | 2.04M | 1.61M | 1.16M |
R&D % of Revenue | - | - | - | - | - |
Other Operating Expenses | -742K | 1.7M | -45K | -100K | 967.08K |
Operating Income | -11.69M▲ 0% | -11.14M▲ 4.7% | -6.07M▲ 45.5% | -4.5M▲ 25.9% | -24.41M▲ 0% |
Operating Margin % | - | - | - | - | - |
Operating Income Growth % | - | 4.7% | 45.51% | 25.86% | - |
EBITDA | -10.51M | -10.42M | -6M | -4.81M | -30.6M |
EBITDA Margin % | - | - | - | - | - |
EBITDA Growth % | - | 0.89% | 42.42% | 19.87% | -1025.11% |
D&A (Non-Cash Add-back) | 1.18M | 724K | 0 | 0 | 0 |
EBIT | -6.23M | -13.95M | -6M | -4.81M | -30.6M |
Net Interest Income | -4.08M | -6.27M | -4.28M | -4.42M | -2.74M |
Interest Income | 0 | 0 | 0 | 0 | 106.64K |
Interest Expense | 4.08M | 6.27M | 4.28M | 4.42M | 2.84M |
Other Income/Expense | 1.38M | -9.08M | -4.21M | -4.73M | -16.26M |
Pretax Income | -10.31M▲ 0% | -20.22M▼ 96.1% | -10.28M▲ 49.1% | -9.23M▲ 10.2% | -40.67M▲ 0% |
Pretax Margin % | - | - | - | - | - |
Income Tax | 0 | 0 | 0 | 0 | 18.92K |
Effective Tax Rate % | 0% | 0% | 0% | 0% | -0.05% |
Net Income | -10.31M▲ 0% | -20.22M▼ 96.1% | -10.28M▲ 49.1% | -9.23M▲ 10.2% | -40.69M▲ 0% |
Net Margin % | - | - | - | - | - |
Net Income Growth % | - | -96.09% | 49.15% | 10.22% | -706.78% |
Net Income (Continuing) | -10.31M | -20.22M | -10.28M | -9.23M | -40.69M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -23.25▲ 0% | -46.50▼ 100.0% | -23.25▲ 50.0% | -21.00▲ 9.7% | -96.18▲ 0% |
EPS Growth % | - | -100% | 50% | 9.68% | -73.91% |
EPS (Basic) | -23.25 | -46.50 | -23.25 | -21.00 | - |
Diluted Shares Outstanding | 437.19K | 437.19K | 437.19K | 437.19K | 423.08K |
Basic Shares Outstanding | 437.19K | 437.19K | 437.19K | 437.19K | 423.08K |
Dividend Payout Ratio | - | - | - | - | - |
PFSA Balance Sheet
Profusa, Inc. Common Stock (PFSA) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
Total Current Assets | 958K | 160K | 333K | 260K | 4.2M |
Cash & Short-Term Investments | 856K | 78K | 142K | 191K | 3.98M |
Cash Only | 856K | 78K | 142K | 191K | 3.01M |
Short-Term Investments | 0 | 0 | 0 | 0 | 972K |
Accounts Receivable | 38K | 0 | 45K | 0 | 0 |
Days Sales Outstanding | - | - | - | - | - |
Inventory | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - |
Other Current Assets | 64K | 82K | 0 | 0 | 0 |
Total Non-Current Assets | 10.4M | 871K | 1.56M | 2.81M | 55K |
Property, Plant & Equipment | 10.11M | 0 | 2K | 0 | 0 |
Fixed Asset Turnover | - | - | - | - | - |
Goodwill | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 0 | 0 | 0 | 9.61M |
Other Non-Current Assets | 293K | 871K | 1.56M | 2.81M | 55K |
Total Assets | 11.36M▲ 0% | 1.03M▼ 90.9% | 1.89M▲ 83.6% | 3.07M▲ 62.3% | 4.25M▲ 0% |
Asset Turnover | - | - | - | - | 0.00x |
Asset Growth % | - | -90.93% | 83.61% | 62.33% | -213.56% |
Total Current Liabilities | 21.61M | 35.65M | 46.74M | 57.13M | 23.54M |
Accounts Payable | 3.26M | 3.43M | 3.99M | 4.95M | 6.98M |
Days Payables Outstanding | - | - | - | - | - |
Short-Term Debt | 15.01M | 31.03M | 40.4M | 48.21M | 6.71M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 1.3M |
Other Current Liabilities | 2.42M | 584K | 1.96M | 3.47M | 5.55M |
Current Ratio | 0.04x | 0.00x | 0.01x | 0.00x | 0.18x |
Quick Ratio | 0.04x | 0.00x | 0.01x | 0.00x | 0.18x |
Cash Conversion Cycle | - | - | - | - | - |
Total Non-Current Liabilities | 73.41M | 65.15M | 65.15M | 65.15M | 14.67M |
Long-Term Debt | 1.19M | 0 | 0 | 0 | 14.36M |
Capital Lease Obligations | 7.07M | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 65.15M | 65.15M | 65.15M | 65.15M | 311K |
Total Liabilities | 95.02M | 100.8M | 111.89M | 122.28M | 38.21M |
Total Debt | 24.02M | 31.03M | 40.4M | 48.21M | 21.07M |
Net Debt | 23.16M | 30.95M | 40.25M | 48.02M | 18.06M |
Debt / Equity | - | - | - | - | -0.62x |
Debt / EBITDA | - | - | - | - | -0.69x |
Net Debt / EBITDA | - | - | - | - | -0.59x |
Interest Coverage | -2.87x | -1.78x | -1.42x | -1.02x | -10.77x |
Total Equity | -83.66M▲ 0% | -99.77M▼ 19.3% | -110M▼ 10.2% | -119.2M▼ 8.4% | -33.96M▲ 0% |
Equity Growth % | - | -19.26% | -10.25% | -8.37% | -5381.71% |
Book Value per Share | -191.35 | -228.21 | -251.60 | -272.66 | -80.27 |
Total Shareholders' Equity | -83.66M | -99.77M | -110M | -119.2M | -33.96M |
Common Stock | 0 | 0 | 0 | 0 | 4K |
Retained Earnings | -85.23M | -105.45M | -115.73M | -124.96M | -152.21M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
PFSA Cash Flow Statement
Profusa, Inc. Common Stock (PFSA) cash flow — operating, investing & free cash flow history
| Metric | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
Cash from Operations | -10.69M | -7.7M | -4.4M | -2.07M | -11.62M |
Operating CF Margin % | - | - | - | - | - |
Operating CF Growth % | - | 27.96% | 42.85% | 53.07% | -723.92% |
Net Income | -10.31M | -20.22M | -10.28M | -9.23M | -40.69M |
Depreciation & Amortization | 1.18M | 724K | 0 | 0 | 0 |
Stock-Based Compensation | 72K | 111K | 33K | 21K | 5K |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -1.11M | 10.77M | 4.3M | 4.74M | 22.04M |
Working Capital Changes | -522K | 909K | 1.54M | 2.41M | 5.42M |
Change in Receivables | 371K | 38K | -45K | 45K | 0 |
Change in Inventory | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -60K | 706K | 533K | 645K | 1.06M |
Cash from Investing | 0 | 0 | -2K | 0 | -7.03M |
Capital Expenditures | 0 | 0 | -2K | 0 | 0 |
CapEx % of Revenue | - | - | - | - | - |
Acquisitions | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | -78.81K |
Cash from Financing | 8.75M | 6.92M | 4.47M | 2.12M | 21.31M |
Debt Issued (Net) | 8.7M | 7.7M | 5.06M | 3.08M | 11.41M |
Equity Issued (Net) | 0 | 0 | 0 | 0 | 404.56K |
Dividends Paid | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 5.92M |
Other Financing | 51K | -772K | -591K | -961K | 452.53K |
Net Change in Cash | -1.94M▲ 0% | -778K▲ 59.9% | 64K▲ 108.2% | 49K▼ 23.4% | 2.83M▲ 0% |
Free Cash Flow | -10.69M▲ 0% | -7.7M▲ 28.0% | -4.4M▲ 42.8% | -2.07M▲ 53.1% | -11.62M▲ 0% |
FCF Margin % | - | - | - | - | - |
FCF Growth % | - | 27.96% | 42.82% | 53.09% | -341.13% |
FCF per Share | -24.45 | -17.62 | -10.07 | -4.73 | -27.47 |
FCF Conversion (FCF/Net Income) | 1.04x | 0.38x | 0.43x | 0.22x | 0.29x |
Interest Paid | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 |
PFSA Key Ratios
Profusa, Inc. Common Stock (PFSA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|
Return on Equity (ROE) | - | - | - | 89.59% |
Return on Invested Capital (ROIC) | - | - | - | 77.19% |
Debt / Equity | - | - | - | -0.62x |
Interest Coverage | -1.78x | -1.42x | -1.02x | -10.77x |
FCF Conversion | 0.38x | 0.43x | 0.22x | 0.29x |
Related:PFSA Dividend History·PFSA Revenue History·PFSA Price History·PFSA P/E History·PFSA Financial Ratios·PFSA Institutional Holders
PFSA Frequently Asked Questions
Profusa, Inc. Common Stock (PFSA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Profusa, Inc. Common Stock (PFSA) grew revenue by 0.0% over the past year. Growth has been modest.
Profusa, Inc. Common Stock (PFSA) reported a net loss of $40.7M for fiscal year 2024.
Dividend & Returns
Profusa, Inc. Common Stock (PFSA) had negative free cash flow of $11.6M in fiscal year 2024, likely due to heavy capital investments.